Carcinogenesis Advance Access published online on January 27, 2007
Carcinogenesis, doi:10.1093/carcin/bgm016
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking, and risk of postmenopausal breast cancer

1 Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263
2 Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892
3 Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA 30329
Corresponding author: Jun Yang, M.D., Ph.D., Department of Epidemiology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14263, Phone: 001-716-845-8937, Fax: 001-716-845-8125, E-mail: Jun.Yang{at}RoswellPark.org
Background: NOS3 and MPO genes encode endothelial nitric oxide synthase (eNOS) and myeloperoxidase (MPO), respectively, which generate nitric oxide and reactive oxygen species. Because cigarette smoking generates reactive species, we hypothesized that NOS3 and MPO polymorphisms could influence susceptibility to breast cancer, particularly among smokers. Methods: We examined the associations between NOS3 Glu298Asp and MPO G-463A polymorphisms and breast cancer risk by cigarette smoking among postmenopausal women in the American Cancer Society's Cancer Prevention Study II Nutrition Cohort. Included in this analysis were 502 women who provided blood samples and were diagnosed with breast cancer between 1992 and 2001, and 505 cancer-free controls who were matched to the cases by age, race/ethnicity, and date of blood donation. Genotyping for NOS3 and MPO was performed using TaqMan, and unconditional logistic regression was used to compute odds ratios (ORs) and 95% confidence intervals (CIs). Results: No statistically significant relationships were found between NOS3 and MPO genotypes and breast cancer risk. When considering smoking, variant NOS3 genotypes (GT & TT) were significantly associated with reduced breast cancer risk among never smokers (OR=0.67, 95% CI=0.45-0.99), but were associated with higher risk among ever smokers (OR=1.59, 95% CI=1.05-2.41) and 2-fold increase in risk for those who smoked more than 10 cigarettes per day (OR=2.19, 95% CI=1.21-3.97). Conclusion: NOS3 genotypes appeared to be associated with risk of postmenopausal breast cancer among smokers, supporting the hypothesis that subgroups of women based upon genetic profiles may be at higher risk of breast cancer when exposed to tobacco smoke.
Key Words: breast cancer nitric oxide synthase myeloperoxidase genetic polymorphism tobacco smoke
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C.-C. Hong, C. B. Ambrosone, J. Ahn, J.-Y. Choi, M. L. McCullough, V. L. Stevens, C. Rodriguez, M. J. Thun, and E. E. Calle Genetic Variability in Iron-Related Oxidative Stress Pathways (Nrf2, NQ01, NOS3, and HO-1), Iron Intake, and Risk of Postmenopausal Breast Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1784 - 1794. [Abstract] [Full Text] [PDF] |
||||
